Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optimeos Life Sciences
Princeton, New Jersey, United States
- Ownership
- Private
- Employees
- ~9
- Development stage
- Other
01
Overview
Optimeos develops a patented non-viral polymeric nanoparticle platform (iFNP/inverse flash nanoprecipitation) for intracellular delivery and long-acting delivery of RNA, DNA, biologics, and small molecules; it is currently applied in preclinical and partnered programs, with no disclosed proprietary clinical-stage assets.[3][4][11]
- Therapeutic areas
- ImmunologyEndocrinologyNeurologyInfectious DiseasesRare DiseasesOncologyOphthalmology
- Modalities
- NanoparticlePolymer-drug conjugate therapymRNA-based drugsDNA vaccineRNA therapySmall interfering RNAAntisense oligonucleotideProteinPeptidesSmall moleculeBiologic
- Industry
- Biotech
02
Partnerships
Integral Molecular (antibody-based molecular targeting for mRNA and DNA gene therapies and vaccines)[4][10]Undisclosed six biopharmaceutical companies for nanoparticle-based delivery of biologics across immuno-oncology, autoimmune, diabetes, CNS and ocular diseases[11]
Beyond the preview
Go deeper on Optimeos Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Optimeos Life Sciences.